News
Zanzalintinib plus Tecentriq significantly improved overall survival versus Stivarga in previously treated metastatic ...
The cancer charity Planets is leading the campaign for the treatment, known as selective internal radiation therapy, to be made available on the NHS.
Research led by the Department of General and Visceral Surgery, Faculty of Medicine, University of Freiburg, Germany has ...
Neighbors organized a car wash fundraiser to support 9-year-old Logan Coyle, a local boy who has faced unimaginable medical ...
Each year, it is estimated more than 40,000 people will be diagnosed with liver cancer – and those numbers are increasing.
Exelixis stock shines with 36% CABOMETYX sales growth, promising zanzalintinib market expansions, and raised 2025 guidance.
Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with ...
7don MSN
Teddy Golubowski was excelling at the Ocean County Police Academy before a rare illness took his life just weeks after his ...
Adjuvant aspirin did not reduce recurrence or improve survival in patients with CRC liver metastases, phase 3 data showed at ...
7d
HealthDay on MSNCRC as First of Multiple Primary Malignancies Tied to Better Outcomes Than CRC as Only MalignancyCompared with colorectal cancer (CRC) presenting as an isolated primary or second primary malignancy, CRC presenting as the ...
Cancer is a disease where abnormal cells grow uncontrollably and can invade other parts of the body. One of the most ...
Hepatocellular carcinoma (HCC), the most common type of liver cancer and the third-leading cause of cancer-related deaths ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results